Category: C.R. BardSyndicate content

Ex-ArthroCare execs face hefty prison sentences | Medtech legal news for the week of September 8, 2014

September 8, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Ex-ArthroCare CEO Baker draws 20 years; Smith & Nephew settles whistleblower lawsuit for $8M; Secant Medical escapes pelvic mesh cases; Bellwether trial kicks off for DePuy's Pinnacle hip implant; J&J, Boston Scientific, others can't shake Philly pelvic mesh mass tort

Ex-ArthroCare CEO Baker draws 20 years

September 2, 2014 by Brad Perriello

Ex-ArthroCare CEO Baker draws 20 years

J&J, Boston Scientific, others can't shake Philly pelvic mesh mass tort

September 4, 2014 by Brad Perriello

Johnson & Johnson, Boston Scientific and several other defendants lose their bid for the wholesale dismissal of more than 860 pelvic mesh product liability lawsuits in a Philadelphia court.

J&J, Boston Scientific, others can't shake Philly pelvic mesh mass tort

ConvaTec said to explore 2015 sale

August 19, 2014 by Brad Perriello

ConvaTec is reportedly weighing a sale of the private-equity-owned medical device company next year, even as interest in a Medtronic-like inversion deal mounts from C.R. Bard, CareFusion and 3M.

ConvaTec said to explore 2015 sale

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

BSX wins personal injury lawsuit over its Pinnacle pelvic mesh product | Medtech legal news for the week of August 4, 2014

August 4, 2014 by MassDevice

Here's a look at some of the top legal news stories for medical device companies this week: Boston Scientific prevails in 1st pelvic mesh trial; Bard settles more than 500 pelvic mesh complaints; Edwards: Q2 brings double-digit sales bump, a major Medtronic settlement and a rosier outlook on the year; Ex-sales rep's counter-claims stand in poaching spat with Stryker; ResMed kicks Apex sleep masks out of Germany

Boston Scientific prevails in 1st pelvic mesh trial

July 30, 2014 by Brad Perriello

Smith & Nephew plans to reveal new strategy for mature markets | Medtech Wall Street news for the week of July 28, 2014

July 31, 2014 by MassDevice

Here's a look at some of the top Wall Street stories for medical device companies this week: Smith & Nephew CEO reveals new 'no frills' strategy; Bard: We're on track for early 2015 Lutonix approval; Ocular Therapeutix prices IPO below range; Philips' healthcare business suffers in Q2; Intersect ENT prices IPO at low end of range

Smith & Nephew CEO reveals new 'no frills' strategy

July 28, 2014 by Brad Perriello

Boston Scientific, other medtech giants weigh in on mega-mergers

July 29, 2014 by Arezu Sarvestani

A recent spate of mega-mergers hasn't inspired medtech peers to follow suit just yet, according to leadership at Boston Scientific, C.R. Bard and Smith & Nephew.

Boston Scientific, other medtech giants weigh in on mega-mergers

The medical device industry has some blockbuster merger activity in recent months, but a few companies are sitting this one out.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Bard settles more than 500 pelvic mesh complaints

July 29, 2014 by Arezu Sarvestani

C.R. Bard closes the books on more than 500 patient injury complaints associated with its Avaulta pelvic mesh implants for an undisclosed amount.

Bard settlement closes more than 500 pelvic mesh complaints

C.R. Bard (NYSE:BCR) managed to close the books on a large chunk of patient complaints against its Avaulta mesh implant, settling more than 500 cases in its 2nd quarter.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp